Press Releases

Fulcrum Therapeutics Announces Initiation of Multi-Center Phase 3 (LOSVID) Trial with Losmapimod for Hospitalized COVID-19 Patients

06/25/2020

Excerpt from the press release: “CAMBRIDGE, Mass., June 24, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that it received early notification from the U.S. Food and Drug Administration (FDA) that the company may proceed with initiating…

Read More

NeuroRx and Relief Therapeutics Announce Fast Track Designation Granted by the FDA to RLF-100 (Aviptadil) for the Treatment of Respiratory Distress in COVID-19

06/24/2020

Excerpt from the press release: “RADNOR, Pa. and GENEVA, June 24, 2020 (GLOBE NEWSWIRE) — NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holding AG (SIX:RLF) “Relief” today announced that the U.S. Food and Drug Administration (FDA) awarded Fast Track Designation to NeuroRx for the investigation of RLF-100 (Aviptadil) for the treatment of acute lung injury/acute…

Read More

TrialStat invites clinical operations leaders and researchers to join them at this year’s SCOPE Summit to explore the latest advances in data management technology

02/17/2019

Montreal-based TrialStat Solutions Inc., a trusted provider of eClinical technology solutions, will be exhibiting at this year’s Summit for Clinical Operations Executives (SCOPE) in Orlando, FL from February 18-21. Christopher Kata, Director, Sales and Marketing, will be conducting demonstrations of TrialStat’s flexible, leading-edge technology built for the needs of today’s life sciences companies. Join Christopher…

Read More

Meet With TrialStat at SCDM to Learn More About The Latest Version of TrialStat EDC

09/14/2018

TrialStat Launches Updated TrialStat EDC at SCDM, Introducing New Features to Further Simplify Your Data Management and Study Collaboration Needs – Meet with us at Booth #312 As the volume of per-trial data grows, compliance requirements increase, and Sponsors are more responsible than ever for trial oversight, TrialStat has responded by releasing the next generation…

Read More